The authors appreciate concern raised by some colleagues with regard to the appropriateness of the third clinical bottom line “Weak evidence suggests an increased risk of necrotising enterocolitis with the use of Gelofusine in neonates” in the article “In neonates requiring intravascular volume resuscitation is the use …